Prostate Rapid Pre-Validation Set

Lead Investigator: Sanda, Martin — Emory University

Coordinating Investigator: Feng, Ziding — Fred Hutchinson Cancer Research Center

Involved Investigator Sites:

• Wagner, Andrew — Beth Israel Deaconess Medical Center
• Sanda, Martin — Emory University
• Feng, Ziding — Fred Hutchinson Cancer Research Center
• Chan, Daniel — Johns Hopkins Medical Institutions
• Partin, Alan W — Johns Hopkins University Department of Urology
• Diamandis, Eleftherios P. — Mount Sinai Hospital
• Srivastava, Sudhir — National Cancer Institute
• Lokshin, Anna — University of Pittsburgh Cancer Instititute
• Leach, Robin J — University of Texas Health Science Center at San Antonio
• Haab, Brian — Van Andel Research Institute

Biomarker Name: hk2, hk4, hk11, TSP-1, %fPSA, -2ProPSA

Design: No design specified.

Field(s) of Research: Other, Specify

Collaborative Group: Prostate and Urologic Cancers Research Group

Phased Status:

Aims: Test candidate prostate markers at various labs using specimens collected and processed in a similar manner.

Analytic Method: N/A

Comments: Specimen Set Depleted

Biomarkers:

• TMPRSS2:ERG
• ST14
• THBS1
• KLK2
• KLK4
• KLK11

Datasets:

No datasets are currently associated with this protocol.